Skip to main content Accessibility help
×
Hostname: page-component-78c5997874-s2hrs Total loading time: 0 Render date: 2024-11-19T02:55:27.601Z Has data issue: false hasContentIssue false

25 - Management commentary

Published online by Cambridge University Press:  13 August 2009

Sophia Frangou
Affiliation:
Section of Neurobiology of Psychosis, Institute of Psychiatry, London, UK
Gordon Parker
Affiliation:
University of New South Wales, Sydney
Get access

Summary

Providing a diagnosis and introducing a management plan

As Parker points out, the diagnosis of Bipolar II Disorder requires detailed history-taking from more than one informant. The identification of hypomanic episodes is more difficult than for manic ones and these may have been overlooked in previous assessments. It is also crucial to engage patients and their families in explaining the diagnosis, its implication and its treatment.

However, it is questionable whether BP II can really be described as a ‘milder form’ or ‘bipolar lite’. At best, one could argue that the prognosis and clinical course of BP II are areas of genuine clinical uncertainty because of poor availability of relevant data. It is regrettable that even large-scale studies addressing its prognosis, treatment and outcome (such as that undertaken by the Stanley Foundation Bipolar Network) have failed to substantially increase our knowledge base about BP II. Some data from this study are, nevertheless, highly relevant in suggesting that the morbidity and disability associated with BP II is at least comparable with that for BP I. For example, Nolen and colleagues (2004) examined the one-year clinical outcome for 258 bipolar disorder patients, of whom 53 had a diagnosis of BP II. They found that the mean overall severity of bipolar disorder was related to the severity of the depressive – and not the manic/hypomanic features.

Type
Chapter
Information
Bipolar II Disorder
Modelling, Measuring and Managing
, pp. 265 - 268
Publisher: Cambridge University Press
Print publication year: 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Bauer, M. S. and Mitchner, L. (2004). What is a “mood stabilizer”? An evidence-based response. American Journal of Psychiatry, 161, 3–18.CrossRefGoogle Scholar
Bowden, C. L., Grunze, H., Mullen, J.et al. (2005). A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder. Journal of Clinical Psychiatry, 66, 111–21.CrossRefGoogle ScholarPubMed
Calabrese, J. R., Keck, P. E. Jr., Macfadden, W.et al. (2005). A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of Bipolar I or II depression. American Journal of Psychiatry, 162, 1351–60.CrossRefGoogle ScholarPubMed
Colom, F., Vieta, E., Sanchez-Moreno, J.et al. (2005). Stabilizing the stabilizer: group psychoeducation enhances the stability of serum lithium levels. Bipolar Disorders, 7 (Suppl. 5), S32–6.CrossRefGoogle ScholarPubMed
Guo, J. J., Keck, P. E. Jr., Corey-Lisle, P. K.et al. (2006). Risk of diabetes mellitus associated with atypical antipsychotic use among patients with bipolar disorder: a retrospective, population-based, case-control study. Journal of Clinical Psychiatry, 67, 1055–61.CrossRefGoogle ScholarPubMed
Judd, L. L., Akiskal, H. S., Schettler, P. J.et al. (2003). A prospective investigation of the natural history of the long-term weekly symptomatic status of Bipolar II Disorder. Archives of General Psychiatry, 60, 261–9.CrossRefGoogle ScholarPubMed
Judd, L. L., Akiskal, H. S., Schettler, P. J.et al. (2005). Psychosocial disability in the course of Bipolar I and II disorders: a prospective, comparative, longitudinal study. Archives of General Psychiatry, 62, 1322–30.CrossRefGoogle ScholarPubMed
Keck, P. E. Jr., McElroy, S. L., Havens, J. R.et al. (2003). Psychosis in bipolar disorder: phenomenology and impact on morbidity and course of illness. Comprehensive Psychiatry, 44, 263–9.CrossRefGoogle ScholarPubMed
Kupka, R. W., Luckenbaugh, D. A., Post, R. M.et al. (2005). Comparison of rapid-cycling and non-rapid-cycling bipolar disorder based on prospective mood ratings in 539 outpatients. American Journal of Psychiatry, 162, 1273–80.CrossRefGoogle ScholarPubMed
Nolen, W. A., Luckenbaugh, D. A., Altshuler, L. L.et al. (2004). Correlates of one-year prospective outcome in bipolar disorder: results from the Stanley Foundation Bipolar Network. American Journal of Psychiatry, 161, 1447–54.CrossRefGoogle Scholar
Perlis, R. H., Baker, R. W., Zarate, C. A. Jr. et al. (2006). Olanzapine versus risperidone in the treatment of manic or mixed states in Bipolar I Disorder: a randomized, double-blind trial. Journal of Clinical Psychiatry, 67, 1747–53.CrossRefGoogle ScholarPubMed
Post, R. M., Denicoff, K. D., Leverich, G. S.et al. (2003). Morbidity in 258 bipolar outpatients followed for one year with daily prospective ratings on the NIMH life chart method. Journal of Clinical Psychiatry, 64, 680–90.CrossRefGoogle Scholar
Schneck, C. D., Miklowitz, D. J., Calabrese, J. R.et al. (2004). Phenomenology of rapid-cycling bipolar disorder: data from the first 500 participants in the Systematic Treatment Enhancement Program. American Journal of Psychiatry, 161, 1902–8.CrossRefGoogle ScholarPubMed
Tohen, M., Greil, W., Calabrese, J. R.et al. (2005). Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial. American Journal of Psychiatry, 162, 1281–90.CrossRefGoogle ScholarPubMed
Tohen, M., Ketter, T. A., Zarate, C. A.et al. (2003). Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study. American Journal of Psychiatry, 160, 1263–71.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • Management commentary
    • By Sophia Frangou, Section of Neurobiology of Psychosis, Institute of Psychiatry, London, UK
  • Edited by Gordon Parker, University of New South Wales, Sydney
  • Book: Bipolar II Disorder
  • Online publication: 13 August 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511544187.027
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • Management commentary
    • By Sophia Frangou, Section of Neurobiology of Psychosis, Institute of Psychiatry, London, UK
  • Edited by Gordon Parker, University of New South Wales, Sydney
  • Book: Bipolar II Disorder
  • Online publication: 13 August 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511544187.027
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • Management commentary
    • By Sophia Frangou, Section of Neurobiology of Psychosis, Institute of Psychiatry, London, UK
  • Edited by Gordon Parker, University of New South Wales, Sydney
  • Book: Bipolar II Disorder
  • Online publication: 13 August 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511544187.027
Available formats
×